Embecta Corp.(EMBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EMBC Embecta Corp.

Pre-Market Trading 11-15 07:07:12 EST

15.05

-0.35

-2.27%

High15.64	Low14.83	Vol200.81K
Open15.60	D1 Closing15.40	Amplitude5.26%
Mkt Cap868.41M	Tradable Cap809.91M	Total Shares57.70M
T/O3.03M	T/O Rate0.37%	Tradable Shares53.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EMBC","market":"US","secType":"STK","nameCN":"Embecta Corp.","latestPrice":15.05,"timestamp":1731618000000,"preClose":15.4,"halted":0,"volume":200813,"delay":0,"floatShares":53814475,"shares":57701830,"eps":1.201492,"marketStatus":"Pre-Market Trading","change":-0.35,"latestTime":"11-15 07:07:12 EST","open":15.6,"high":15.64,"low":14.83,"amount":3031761.462034,"amplitude":0.052597,"askPrice":16.75,"askSize":5,"bidPrice":14.01,"bidSize":40,"shortable":3,"etf":0,"ttmEps":1.201492,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1731681000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":15.05,"dividendRate":0.039867,"postHourTrading":{"tag":"盘后","latestPrice":15.05,"preClose":15.05,"latestTime":"16:20 EST","volume":18716,"amount":281675.53,"timestamp":1731619201026},"volumeRatio":0.6407709430874462,"impliedVol":1.0274,"impliedVolPercentile":0.9363},"requestUrl":"/m/hq/s/EMBC","defaultTab":"news","newsList":[{"id":"2483008063","title":"embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483008063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483008063?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:00","pubTimestamp":1731448800,"startTime":"0","endTime":"0","summary":"PARSIPPANY, N.J., Nov. 12, 2024  -- Embecta Corp.  , a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time  on Thursday, November 26, 2024.A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 21, 2024, via the embecta investor relations website and archived on the website for one year.About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visitembecta.comor follow our social channels onLinkedIn,Facebook,and Instagram.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/20siTFtX1CuHpHsoOSUuiA--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f9a8427beeb58b5500a67e3aeeed0f3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/20siTFtX1CuHpHsoOSUuiA--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f9a8427beeb58b5500a67e3aeeed0f3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-report-fiscal-fourth-quarter-220000941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4561","BK4585","BK4581","BK4588","EMBC","ET","BK4198","BK4590","BK4144"],"gpt_icon":0},{"id":"2469297972","title":"Embecta Corp.: Navigating Through A Changing Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=2469297972","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469297972?lang=en_us&edition=fundamental","pubTime":"2024-09-22 19:20","pubTimestamp":1727004038,"startTime":"0","endTime":"0","summary":"Today, we take our first look at Embecta Corp, a spinoff from Becton, Dickinson, that focuses on diabetes products and recently received FDA approval for a new patch pump.Despite beating Q3 earnings expectations, Embecta faces challenges with declining revenues, a high debt load, and a changing environment.By some metrics, the stock is cheap, and the company has brought in advisors to explore a potential sale of the firm.Buy, Sell, or Hold?","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/926358710/image_926358710.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/926358710/image_926358710.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4722535-embecta-corp-navigating-through-a-changing-landscape","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU1854104046.USD","BK4198","BK4082","BK4585","BK4504","BDX","LU1059921491.USD","LU0289739343.SGD","LU0266013472.USD","LU0289961442.SGD","LU0511384066.AUD","LU1571399168.USD","LU1854103824.USD","BK4588","EMBC","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2464309215","title":"Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2464309215","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464309215?lang=en_us&edition=fundamental","pubTime":"2024-09-04 20:22","pubTimestamp":1725452520,"startTime":"0","endTime":"0","summary":"The clearance of this insulin delivery system is expected to significantly enhance Embecta's market prospects. Historically, most insulin pumps were designed for Type 1 diabetes  patients, leaving a gap in the market for T2D-specific solutions. By addressing this gap, Embecta is poised to capture a larger share of the diabetes care market, particularly among the vast population of T2D patients. Investors also cheered the FDA clearance, as evident from the EMBC stock’s gain of 0.7% on Sept. 3 following the announcement.Shares of the company have risen 22.2% in the past six months compared with the industry’s 2.9% growth. The S&P 500 Index has gained 11.7% in the same time frame.Features of EMBC’s Disposable Insulin Delivery System. EMBC is already working on a closed-loop version of the insulin delivery system, which will include an advanced insulin-dosing algorithm. This next-generation system is expected to offer even greater convenience and precision in insulin management, further so","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/exICdiN3pRo85wyejmNeSw--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/exICdiN3pRo85wyejmNeSw--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-stock-gains-fda-clearance-122200571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJT1NW94.SGD","BK4504","LU1061106388.HKD","BK4581","BK4585","LU0077335932.USD","BK4588","IE00BJJMRZ35.SGD","LU2362541273.HKD","LU2491049909.HKD","LU1989772840.SGD","LU0267386448.USD","BSX","LU1989764664.SGD","LU2112291526.USD","LU2244417387.USD","BK4198","UHS","APYX","LU0353189763.USD","LU1989764748.USD","LU2491050154.USD","LU2087625088.SGD","LU2491050071.SGD","LU0882574055.USD","LU0011850046.USD","LU2362540622.SGD","LU0266013472.USD","BK4082","LU2362541513.USD","LU0950375773.USD","LU1804176565.USD","LU2324357040.USD","IE0009355771.USD","LU0122379950.USD","LU1989771016.USD","LU0353189680.USD","LU1023059063.AUD","LU1989772923.USD","EMBC","LU0823417737.USD","BK4185","IE0002141913.USD","LU0528227936.USD","LU1057294990.SGD","LU1983299246.USD","LU0114720955.EUR","LU1291159041.SGD","LU0238689110.USD","LU0187121727.USD"],"gpt_icon":0},{"id":"2464587374","title":"BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2464587374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464587374?lang=en_us&edition=fundamental","pubTime":"2024-09-04 20:19","pubTimestamp":1725452355,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Marie Thibault from BTIG reiterated a Hold rating on Embecta Corporation (EMBC – Research Report). The company’s sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-hold-rating-on-embecta-corporation-embc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-hold-rating-on-embecta-corporation-embc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMBC"],"gpt_icon":0},{"id":"2464218384","title":"BUZZ-Embecta rises on US FDA clearance of its insulin patch pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2464218384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464218384?lang=en_us&edition=fundamental","pubTime":"2024-09-04 00:21","pubTimestamp":1725380486,"startTime":"0","endTime":"0","summary":"** Shares of Embecta    rise 1.6% to $16.60   ** Medical device maker says the U.S. FDA has cleared its disposable insulin patch pump for use in adults who have type 1 or type 2 diabetes   ** EMBC also plans to submit an application to the FDA for potential approval of a closed-loop version of its pump with an insulin-dosing algorithm    ** YTD, stock up 12.3%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4198","EMBC"],"gpt_icon":0},{"id":"2464386046","title":"Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2464386046","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464386046?lang=en_us&edition=fundamental","pubTime":"2024-09-03 23:37","pubTimestamp":1725377851,"startTime":"0","endTime":"0","summary":"Embecta  said Tuesday it has received the US Food and Drug Administration's 510 clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.Shares of Embecta were up 2.3% in recent Tuesday trading.Price: 16.72, Change: +0.38, Percent Change: +2.33","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMBC","BK4198"],"gpt_icon":0},{"id":"2464869643","title":"Embecta gets FDA clearance for type 2 diabetes patch pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2464869643","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464869643?lang=en_us&edition=fundamental","pubTime":"2024-09-03 22:24","pubTimestamp":1725373472,"startTime":"0","endTime":"0","summary":"Embecta  has received FDA clearance for its disposable insulin delivery system for the treatment of both type 1 and type 2 diabetes. The system includes a tubeless patch pump with a 300-unit insulin reservoir and a locked-down controller with Bluetooth technology.   Embecta said the 300-unit reservoir design is aimed at accommodating the needs of type 2 diabetics who have higher daily insulin needs, according to a statement. Embecta added it is also working on a closed-loop patch pump device that includes an insulin-dosing algorithm.  Wells Fargo pointed out that Insulet  recently received FDA clearance for its Omnipod 5 insulin delivery system for type 2 diabetes, while Tandem Diabetes Care  expects to submit an application to get its device approved for type 2 diabetes “shortly.” The investment bank noted that Insulet’s Omnipod 5 only has a 200-unit reservoir versus Embecta’s 300-unit.  “This is important because people with type 2 tend to use more insulin,” the bank added.","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215516118/image_1215516118.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215516118/image_1215516118.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4146224-embecta-gets-fda-clearance-for-type-2-diabetes-patch-pump","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4588","BK4551","PODD","TNDM","BK4082","BK4566","EMBC","BK4585","BK4198"],"gpt_icon":0},{"id":"2464876398","title":"Embecta Corp: Co's Patch Pump Development Program Includes Plans for Closed-Loop Version Including Insulin-Dosing Algorithm in Future FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2464876398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464876398?lang=en_us&edition=fundamental","pubTime":"2024-09-03 18:30","pubTimestamp":1725359400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240903:nTUA4DSWW7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","EMBC"],"gpt_icon":0},{"id":"2464750578","title":"Embecta Announces FDA Clearance of Its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People With Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2464750578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464750578?lang=en_us&edition=fundamental","pubTime":"2024-09-03 18:30","pubTimestamp":1725359400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240903:nTUA4DSWW7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EMBC","BK4198"],"gpt_icon":0},{"id":"2464087666","title":"embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2464087666","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464087666?lang=en_us&edition=fundamental","pubTime":"2024-09-03 18:30","pubTimestamp":1725359400,"startTime":"0","endTime":"0","summary":"While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin reservoir is more suitable for people with T2D who are interested in moving from multiple daily injections  to pump therapy, based on an average daily dose of 95.9 units of insulin.1. “Our research and development, medical affairs and regulatory teams identified an unmet need within the diabetes community and shepherded this project from concept to clearance with dedication and diligence,” said Dr. Colleen Riley, Chief Technology Officer. “I want to thank the embecta team for their commitment to serving people with diabetes and thank the FDA for their timely review and clearance of a system that has the potentia","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/20siTFtX1CuHpHsoOSUuiA--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f9a8427beeb58b5500a67e3aeeed0f3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/20siTFtX1CuHpHsoOSUuiA--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f9a8427beeb58b5500a67e3aeeed0f3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-announces-fda-clearance-disposable-103000591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EMBC","BK4198"],"gpt_icon":0},{"id":"2460222902","title":"Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2460222902","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460222902?lang=en_us&edition=fundamental","pubTime":"2024-08-16 21:03","pubTimestamp":1723813389,"startTime":"0","endTime":"0","summary":"The board of Embecta Corp. ( NASDAQ:EMBC ) has announced that it will pay a dividend of $0.15 per share on the 13th of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-embc/embecta/news/embecta-nasdaqembc-will-pay-a-dividend-of-015","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2210150020.SGD","BK4198","SQQQ","EMBC","TQQQ",".IXIC","LU2210149790.SGD","PSQ","NQmain","QID","QLD","BK4588","BK4585","BK4112","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","MNQmain"],"gpt_icon":1},{"id":"2459211170","title":"Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There","url":"https://stock-news.laohu8.com/highlight/detail?id=2459211170","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459211170?lang=en_us&edition=fundamental","pubTime":"2024-08-16 20:44","pubTimestamp":1723812254,"startTime":"0","endTime":"0","summary":"The market seemed underwhelmed by last week's earnings announcement from Embecta Corp.  despite the healthy numbers. We did some analysis to find out why and believe that investors might be missing some encouraging factors contained in the earnings.NasdaqGS:EMBC Earnings and Revenue History August 16th 2024. For anyone who wants to understand Embecta's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$28m due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Embecta to produce a higher profit next year, all else being equal.Because unusual items detracted ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S0lfvVFvT2zEUqilo.yhog--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2260c3158cb31199a7e2c221586ac549","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S0lfvVFvT2zEUqilo.yhog--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2260c3158cb31199a7e2c221586ac549"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-nasdaq-embc-posting-promising-124414230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","EMBC",".IXIC"],"gpt_icon":0},{"id":"2459642651","title":"Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2459642651","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459642651?lang=en_us&edition=fundamental","pubTime":"2024-08-15 19:39","pubTimestamp":1723721940,"startTime":"0","endTime":"0","summary":"Embecta Corp.  has announced that it will pay a dividend of $0.15 per share on the 13th of September. The dividend yield will be 4.1% based on this payment which is still above the industry average.A big dividend yield for a few years doesn't mean much if it can't be sustained. Based on the last dividend, Embecta is earning enough to cover the payment, but then it makes up 253% of cash flows. While the company may be more focused on returning cash to shareholders than growing the business at this time, we think that a cash payout ratio this high might expose the dividend to being cut if the business ran into some challenges.The next year is set to see EPS grow by 104.9%. If the dividend continues along recent trends, we estimate the payout ratio will be 24%, which is in the range that makes us comfortable with the sustainability of the dividend.Get in touch with us directly. Alternatively, e","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S0lfvVFvT2zEUqilo.yhog--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2260c3158cb31199a7e2c221586ac549","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S0lfvVFvT2zEUqilo.yhog--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2260c3158cb31199a7e2c221586ac549"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-nasdaq-embc-due-pay-113900821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210150020.SGD","TQQQ","QID","EMBC","MNQmain",".IXIC","BK4588","LU2095319765.USD","NQmain","BK4585","IE00BKPKM429.USD","LU2210149790.SGD","BK4198","NDAQ","SQQQ","BK4112","PSQ","QLD"],"gpt_icon":1},{"id":"2459196334","title":"Embecta Corporation Announces Chief Accounting Officer Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2459196334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459196334?lang=en_us&edition=fundamental","pubTime":"2024-08-13 05:30","pubTimestamp":1723498218,"startTime":"0","endTime":"0","summary":"Embecta Corporation (EMBC) has provided an update. Embecta Corp. has announced the resignation of Brian Capone, the Chief Accounting Officer, effec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/embecta-corporation-announces-chief-accounting-officer-resignation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/embecta-corporation-announces-chief-accounting-officer-resignation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","EMBC"],"gpt_icon":0},{"id":"2458256980","title":"Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average","url":"https://stock-news.laohu8.com/highlight/detail?id=2458256980","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458256980?lang=en_us&edition=fundamental","pubTime":"2024-08-12 21:35","pubTimestamp":1723469704,"startTime":"0","endTime":"0","summary":"From a technical perspective, Embecta Corp.  is looking like an interesting pick, as it just reached a key level of support. EMBC recently overtook the 20-day moving average, and this suggests a short-term bullish trend.The 20-day simple moving average is a well-liked trading tool because it provides a look back at a stock's price over a 20-day period. Additionally, short-term traders find this SMA very beneficial, as it smooths out short-term price trends and shows more trend reversal signals than longer-term moving averages.Similar to other SMAs, if a stock's price moves above the 20-day, the trend is considered positive, while price falling below the moving average can signal a downward trend.Shares of EMBC have been moving higher over the past four weeks, up 16.9%. Plus, the company is currently a Zacks Rank #2  stock, suggesting that EMBC could be poised for a continued surge.Investors should think about putting EMBC on their watchlist given the ultra-important technical indicator","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-corp-embc-recently-broke-133504238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","EMBC"],"gpt_icon":0},{"id":"2458369142","title":"Embecta Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2458369142","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458369142?lang=en_us&edition=fundamental","pubTime":"2024-08-11 22:04","pubTimestamp":1723385055,"startTime":"0","endTime":"0","summary":"NasdaqGS:EMBC Earnings and Revenue Growth August 11th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.9%. Earnings per share  also surpassed analyst estimates by 79%.Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 8.2% growth forecast for the Medical Equipment industry in the US.The company's shares are up 2.5% from a week ago.You still need to take note of risks, for example - Embecta has   4 warning signs    we think you should know about.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/embecta-third-quarter-2024-earnings-140415616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EMBC"],"gpt_icon":0},{"id":"2458631510","title":"Embecta Shares Rise After Fiscal Q3 Beat; Fiscal 2024 EPS Guidance Raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2458631510","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458631510?lang=en_us&edition=fundamental","pubTime":"2024-08-10 02:39","pubTimestamp":1723228750,"startTime":"0","endTime":"0","summary":"Embecta  shares were up nearly 6% in recent trading on Friday after the company's fiscal Q3 results topped market expectations and raised its 2024 EPS guidance.The company reported fiscal Q3 adjusted earnings of $0.74 per diluted share, up from $0.69 a year earlier.Analysts polled by Capital IQ expected $0.46.Revenue for the quarter ended June 30 was $272.5 million, down from $286.1 million a year earlier.Four analysts surveyed by Capital IQ expected $267.4 million.The company said it now expects fiscal 2024 adjusted EPS of $2.30 to $2.35 per diluted share, up from its prior guidance of $2.20 to $2.30. Analysts polled by Capital IQ expect $2.28.The company's revenue guidance for the fiscal year remained unchanged at $1.11 billion to $1.12 billion. Analysts surveyed by Capital IQ expect $1.11 billion.Price: 15.19, Change: +0.85, Percent Change: +5.93","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMBC"],"gpt_icon":0},{"id":"2458472510","title":"Embecta Shares Rise After Fiscal Q3 Beat; Fiscal 2024 EPS Guidance Raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2458472510","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458472510?lang=en_us&edition=fundamental","pubTime":"2024-08-10 02:39","pubTimestamp":1723228750,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4505","BK4531","IQ","BK4526","EMBC","BK4552","BK4198","BK4108"],"gpt_icon":0},{"id":"2458759115","title":"Embecta Keeps Quarterly Dividend at $0.15 a Share, Payable Sept. 13 to Shareholders as of Aug. 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2458759115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458759115?lang=en_us&edition=fundamental","pubTime":"2024-08-09 22:06","pubTimestamp":1723212380,"startTime":"0","endTime":"0","summary":"Price: 16.44, Change: +2.10, Percent Change: +14.64","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMBC"],"gpt_icon":0},{"id":"2458591482","title":"Embecta Keeps Quarterly Dividend at $0.15 a Share, Payable Sept. 13 to Shareholders as of Aug. 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2458591482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458591482?lang=en_us&edition=fundamental","pubTime":"2024-08-09 22:06","pubTimestamp":1723212380,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["EMBC","BK4198"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.embecta.com","stockEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":0.1115},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.0415},{"period":"1year","weight":-0.0829},{"period":"ytd","weight":-0.205}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.","exchange":"NASDAQ","name":"Embecta Corp.","nameEN":"Embecta Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Embecta Corp.(EMBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Embecta Corp.(EMBC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Embecta Corp.,EMBC,Embecta Corp.股票,Embecta Corp.股票老虎,Embecta Corp.股票老虎国际,Embecta Corp.行情,Embecta Corp.股票行情,Embecta Corp.股价,Embecta Corp.股市,Embecta Corp.股票价格,Embecta Corp.股票交易,Embecta Corp.股票购买,Embecta Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Embecta Corp.(EMBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Embecta Corp.(EMBC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}